A new study published in the Journal of Hepatocellular Carcinoma showed that minimally invasive hepatectomy (MIH) offers ...

Studies have shown that inflammation and unhealthy ageing contribute to the development of non-viral liver cancer. However, researchers have now discovered that drinking one type of tea could ...

Medical devicemakers are tapping into electric fields as a new treatment for cancer, The Wall Street Journal reported May 16.  For decades, electricity has been used to treat cardiovascular conditions ...

Hepatic artery infusion (HAI) therapy offers a new approach for people whose colorectal cancer has spread to the liver. It allows physicians to deliver chemotherapy directly to the liver at doses up ...

Research has indicated that inflammation and unhealthy ageing can lead to the development of non-viral liver cancer. However, scientists have now found that consuming a certain type of tea could ...

Our liver is one of the most important organs of the body, performing important tasks like digestion, detoxification, and metabolism, acting as a filter for blood and performing hundreds of other ...

Surgery is rarely indicated in these circumstances. Infrequently, benign liver tumors are diagnosed because of symptoms or complications, and require urgent management including surgery as a major ...

wanted to improve a category of focused ultrasound known as mechanical tumor ablation. This technique uses energy to destroy solid tumors without surgery. However, using focused ultrasound to treat ...

The hormone works primarily by signaling the brain to improve liver ... Liver Cancer Survival Rates Reflect Income Disparities May 5, 2025 — The risk of dying from the most common form of ...

Two phase 3 trials of Merck & Co's Keytruda in metastatic castration-resistant prostate cancer (CRPC) and advanced liver cancer have ended in failure, proving once again that cancer immunotherapy ...

Retifanlimab-dlwr is approved for first-line treatment of advanced anal cancer, both in combination with chemotherapy and as monotherapy. Phase 3 trial results showed a 37% reduction in ...